Stock is 31 less 12 in cash/share = 19Earnings will exceed 4.00 next year.P/E ratio is less than 5.Keep selling.Next earnings will bring cash up another rung in the value ladder as in every quarter.Pretty soon somebody is going to notice this and come in with a takeover for its pipeline... which looks good based on ongoing clinical trials.
Would expect share price to exceed $35 by the end of the wk. With 10 mil shares short I would put any sell orders out a few days.
According to Nasd there are over 20 million shares short with 13 days needed to cover. Looking good for the longs. Should see upgrades tomorrow.